Fundz

Nuvaira, Inc. reported raising $17.4 Million in an initial SEC Form D filing, from an offering of $50 Million

PRIVATEJul 29, 2020$17.4M of $50M raised

Amount Raised

$17.4 Million

$17.4 Million sold, per SEC Form D (first sale Jul 29, 2020)

Round Type

Venture

Maple GroveHealthcaremedical devices

Who else raised in Healthcare and medical devices around the same time

Companies in the same sectors as Nuvaira that raised within 45 days of this round, from Fundz verified event records.

  • GENEREX BIOTECHNOLOGY CORP raised $2M (Seed) on September 11, 2020.
  • Health Care Solutions Inc. raised $1M (Seed) on September 11, 2020.
  • Metabolon raised $22M on September 11, 2020.
  • BioIntelliSense raised $25M on September 10, 2020.
  • ResQ Pharma, Inc. raised $1M (Seed) on September 10, 2020.
  • Expanesthetics, Inc raised $261K (Seed) on September 10, 2020.

Who to call at Nuvaira, and when

A new round usually means Nuvaira is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Nuvaira raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Nuvaira, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nuvaira. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nuvaira

Location

6500 Wedgwood Road North, Suite 100

Maple Grove, Minnesota, United States

About

Nuvaira, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of the more than 65 million people around the world with obstructive lung disease. Founded in 2008, Nuvaira was established to address clinical needs in the treatment of overactive airway nerves, a common disease feature of both COPD and asthma. Nuvaira is a privately held medical device company, headquartered in Minneapolis, Minnesota USA and has more than 75 patents issued and pending worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nuvaira raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsTom G., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Nuvaira's next move

See what Strategic adds

Nuvaira raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.